# Effect of Adjunctive Use of Vitamin B3 and B9 on Myeloperoxidase Level in the GCF of Patients With Stage I and II Periodontitis

> **NCT05435378** · EARLY_PHASE1 · UNKNOWN · sponsor: **Cairo University** · enrollment: 30 (estimated)

## Conditions studied

- Periodontitis Stage I
- Periodontal Diseases
- Periodontal Inflammation
- Periodontal Attachment Loss
- Periodontitis
- Periodontitis Stage II

## Interventions

- **DRUG:** Vitamin B3 100 MG Oral Tablet
- **DRUG:** vitamin B9
- **DRUG:** Placebo
- **PROCEDURE:** full mouth non surgical periodontal treatment

## Key facts

- **NCT ID:** NCT05435378
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05435378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05435378, "Effect of Adjunctive Use of Vitamin B3 and B9 on Myeloperoxidase Level in the GCF of Patients With Stage I and II Periodontitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05435378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*